Considerations in Primary Packaging Component Selection for Parenteral Drug Delivery

14 December 2020 10:10 - 10:45

  • Present the key considerations in selecting the appropriate parenteral packaging components.
  • Introduce solutions for manufacturing high-quality packaging components to meet the needs of the pharmaceutical industry.
  • Discuss risks that face the pharmaceutical industry today from a drug packaging perspective, and strategies to mitigate these risks.


The component selection process is a critical step in developing safe and effective primary packaging for pharmaceutical and biotech drugs. Considerations in component selection may involve evaluating a variety of elastomer compounds, assessing the need for additional protection through elastomer coatings, and establishing the best final seal, if applicable, to ensure the packaging maintains the drug product integrity.

Eugene Polini, Technical Key Account Manager, Datwyler

Back to programme